Canada markets open in 8 hours 33 minutes

Biomark Diagnostics Inc. (BUX.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2400+0.0050 (+2.13%)
At close: 02:42PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 21.81M
Enterprise Value 22.58M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)124.48
Price/Book (mrq)N/A
Enterprise Value/Revenue 138.41
Enterprise Value/EBITDA -27.36

Trading Information

Stock Price History

Beta (5Y Monthly) -0.55
52-Week Change 3-20.00%
S&P500 52-Week Change 325.87%
52 Week High 30.3300
52 Week Low 30.0000
50-Day Moving Average 30.2485
200-Day Moving Average 30.2750

Share Statistics

Avg Vol (3 month) 321.28k
Avg Vol (10 day) 32.16k
Shares Outstanding 590.89M
Implied Shares Outstanding 690.89M
Float 839.17M
% Held by Insiders 150.26%
% Held by Institutions 10.00%
Shares Short (Jun 14, 2024) 4467
Short Ratio (Jun 14, 2024) 40.04
Short % of Float (Jun 14, 2024) 4N/A
Short % of Shares Outstanding (Jun 14, 2024) 40.00%
Shares Short (prior month May 15, 2024) 43.27k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,005.53%

Management Effectiveness

Return on Assets (ttm)-98.51%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)163.16k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)12.60%
Gross Profit (ttm)N/A
EBITDA -1.75M
Net Income Avi to Common (ttm)-1.54M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)313.03k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.82M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.28
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-943.28k
Levered Free Cash Flow (ttm)-674.81k